Abstract:The phosphorylated RNA polymerase II CTD interacting factor 1 (PCIF1) is a methyltransferase that adds a methyl group to the N6-position of 2'O-methyladenosine (Am), generating N6, 2'O-dimethyladenosine (m6Am) when Am is the cap-proximal nucleotide. In addition, PCIF1 has ancillary methylation activities on internal adenosines (both A and Am), although with much lower catalytic efficiency relative to that of its preferred cap substrate. The PCIF1 preference for 2'O-methylated Am over unmodified A nucleosides is due mainly to increased binding affinity for Am. Importantly, it was recently reported that PCIF1 can methylate viral RNA. Although some viral RNA can be translated in the absence of a cap, it is unclear what roles PCIF1 modifications may play in the functionality of viral RNAs. Here we show, using in vitro assays of binding and methyltransfer, that PCIF1 binds an uncapped 5'-Am oligonucleotide with approximately the same affinity as that of a cap analog (KM = 0.4 versus 0.3 μM). In addition, PCIF1 methylates the uncapped 5'-Am with activity decreased by only fivefold to sixfold compared with its preferred capped substrate. We finally discuss the relationship between PCIF1-catalyzed RNA methylation, shown here to have broader substrate specificity than previously appreciated, and that of the RNA demethylase fat mass and obesity-associated protein (FTO), which demonstrates PCIF1-opposing activities on capped RNAs.

The Mammalian Cap-Specific m6Am RNA Methyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues

Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity

Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome

PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression

Cap-specific terminal N 6-methylation of RNA by an RNA polymerase II-associated methyltransferase

Cap-specific Terminal N6-methyladeonsine Methylation of RNA Mediated by PCIF1 and Possible Therapeutic Implications

The cap-specific m6A methyltransferase, PCIF1/CAPAM, is dynamically recruited to the gene promoter in a transcription-dependent manner

Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs

PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine

Targeted Manipulation of Cellular RNA m6A Methylation at theSingle-Base Level br

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells

The catalytic-dead Pcif1 regulates gene expression and fertility in Drosophila

CAPAM: The mRNA Cap Adenosine N6-Methyltransferase

m6Am methyltransferase PCIF1 negatively regulates ciliation by inhibiting BICD2 expression

Trinucleotide mRNA Cap Analogue N 6-Benzylated at the Site of Posttranscriptional m6 A m Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo

Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA

M6am Methyltransferase PCIF1 is Essential for Aggressiveness of Gastric Cancer Cells by Inhibiting TM9SF1 Mrna Translation.

m6Am Methyltransferase PCIF1 Regulates Periodontal Inflammation

Essential roles of RNA cap-proximal ribose methylation in mammalian embryonic development and fertility

m 6 Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation